Next Article in Journal
TRP Channels as Sensors of Aldehyde and Oxidative Stress
Next Article in Special Issue
Recent Advances in Translational Adipose-Derived Stem Cell Biology
Previous Article in Journal
Surface Modulation of Graphene Oxide for Amidase Immobilization with High Loadings for Efficient Biocatalysis
Previous Article in Special Issue
Chronic DDE Exposure Modifies Mitochondrial Respiration during Differentiation of Human Adipose-Derived Mesenchymal Stem Cells into Mature Adipocytes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Time-Dependent Reduction of Calcium Oscillations in Adipose-Derived Stem Cells Differentiating towards Adipogenic and Osteogenic Lineage

by
Enrico C. Torre
1,2,3,
Mesude Bicer
1,4,
Graeme S. Cottrell
5,
Darius Widera
1,*,† and
Francesco Tamagnini
2,*,†
1
Stem Cell Biology and Regenerative Medicine Group, School of Pharmacy, University of Reading, Whiteknights, Reading RG6 6LA, UK
2
Neuronal and Cellular Physiology Group, School of Pharmacy, University of Reading, Whiteknights, Reading RG6 6LA, UK
3
Biomedicine West Wing, International Centre for Life, Times Square, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK
4
Department of Bioengineering, Sumer Campus, Abdullah Gül University, Kayseri 38080, Turkey
5
Cellular and Molecular Neuroscience, School of Pharmacy, University of Reading, Reading RG6 6LA, UK
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Biomolecules 2021, 11(10), 1400; https://doi.org/10.3390/biom11101400
Submission received: 13 July 2021 / Revised: 16 September 2021 / Accepted: 20 September 2021 / Published: 23 September 2021
(This article belongs to the Special Issue Recent Advances in Translational Adipose-Derived Stem Cell Biology)

Abstract

:
Adipose-derived mesenchymal stromal cells (ASCs) are multipotent stem cells which can differentiate into various cell types, including osteocytes and adipocytes. Due to their ease of harvesting, multipotency, and low tumorigenicity, they are a prime candidate for the development of novel interventional approaches in regenerative medicine. ASCs exhibit slow, spontaneous Ca2+ oscillations and the manipulation of Ca2+ signalling via electrical stimulation was proposed as a potential route for promoting their differentiation in vivo. However, the effects of differentiation-inducing treatments on spontaneous Ca2+ oscillations in ASCs are not yet fully characterised. In this study, we used 2-photon live Ca2+ imaging to assess the fraction of cells showing spontaneous oscillations and the frequency of the oscillation (measured as interpeak interval—IPI) in ASCs undergoing osteogenic or adipogenic differentiation, using undifferentiated ASCs as controls. The measurements were carried out at 7, 14, and 21 days in vitro (DIV) to assess the effect of time in culture on Ca2+ dynamics. We observed that both time and differentiation treatment are important factors associated with a reduced fraction of cells showing Ca2+ oscillations, paralleled by increased IPI times, in comparison with untreated ASCs. Both adipogenic and osteogenic differentiation resulted in a reduction in Ca2+ dynamics, such as the fraction of cells showing intracellular Ca2+ oscillations and their frequency. Adipogenic differentiation was associated with a more pronounced reduction of Ca2+ dynamics compared to cells differentiating towards the osteogenic fate. Changes in Ca2+ associated oscillations with a specific treatment had already occurred at 7 DIV. Finally, we observed a reduction in Ca2+ dynamics over time in untreated ASCs. These data suggest that adipogenic and osteogenic differentiation cell fates are associated with specific changes in spontaneous Ca2+ dynamics over time. While this observation is interesting and provides useful information to understand the functional correlates of stem cell differentiation, further studies are required to clarify the molecular and mechanistic correlates of these changes. This will allow us to better understand the causal relationship between Ca2+ dynamics and differentiation, potentially leading to the development of novel, more effective interventions for both bone regeneration and control of adipose growth.

1. Introduction

Mesenchymal stem cells (MSCs) are multipotent, fibroblast-like cells that can be readily obtained from various adult tissues including the bone marrow, adipose tissue, and peripheral blood as well as from prenatal tissues such as amniotic fluid, umbilical cord, and placenta. However, as they are derived from the mesoderm, their differentiation spectrum is limited to mesenchymal derivatives such as bone, fat, and cartilage (see [1] for review). Nevertheless, as of July 2021, over 1200 clinical trials involving MSCs have been registered on the ClinicalTrials.gov database with wide indication profiles including diabetes, cardiovascular disorders, in addition to musculoskeletal symptoms. Indeed, transplantation of MSCs has been shown to alleviate symptoms of a broad spectrum of conditions including liver cirrhosis (affected germ layer: endoderm) [2], severe ischaemic heart failure (affected germ layer: mesoderm) [3], and progressive multiple sclerosis (affected germ layer: ectoderm) [4]. Despite the lack of differentiation beyond the mesodermal germ layer boundary, their surprising ability to improve all these conditions can be explained by bystander effects mediated by secretion of paracrine factors [5,6,7,8,9,10].
Adipose-derived stem cells (ASCs) are tissue-resident ASCs that can be isolated from lipo-aspirates [11]. Notably, their differentiation potential towards the mesenchymal fate is comparable to that of ASCs from other organs including the bone marrow [12,13]. Moreover, like bone marrow ASCs, they are also able to contribute to regeneration of various tissues via paracrine effects [13,14,15].
Intracellular Ca2+ is a well-known second messenger, involved in downstream signalling cascades and numerous cell functions, including proliferation, differentiation, and apoptosis [16]. It has been demonstrated that oscillations of intracellular Ca2+ are associated and causally related to the ability of single cells to process environmental inputs, encode information, and generate an adequate behavioural response: this is known as Ca2+ encoding or the Ca2+ code [17,18].
ASCs have been reported to exhibit spontaneous Ca2+ oscillations and this has been linked to the activity of Ca2+ channels and pumps on both the plasma membrane and the endoplasmic reticulum [19,20]. The Ca2+ oscillations are triggered by an ATP-dependent autocrine and paracrine signalling loop and subsequently sustained and amplified by inositol triphosphate (IP3)-dependent release from internal stores and by an activation of plasma membrane Ca2+ channels [21]. The downstroke phase of the Ca2+ oscillation is then mediated by the sarco/endoplasmic reticulum Ca2+-ATPase pumps (SERCA) and the plasma membrane Ca2+-ATPase pumps (PMCA), but not the Na+/Ca2+ exchanger [22]. Importantly, the association between specific differentiation pathways and the features of the intracellular Ca2+ oscillation, such as the fraction of cells showing such activity and the frequency of the event, is still not fully understood. Understanding and establishing the association between the features of the intracellular Ca2+ oscillation and the cell fate can be a powerful tool for screening libraries of stem cell-derived cytotypes and will allow us to acquire further insights on the functional correlates of the differentiation process. In fact, measuring Ca2+ dynamics in differentiating cells may become an alternative or complementary method to measuring the specific morphological and molecular markers which are currently used to establish the specialisation of a differentiated stem cell-derived cytotype and assess their functional maturity [23]. However, we are still lacking information allowing us to associate specific intracellular Ca2+ patterns with different cell fates. One complication which might hinder the deciphering of the Ca2+ code, is that intracellular Ca2+ dynamics are not only affected by the differentiation protocol, but also by time, especially in undifferentiated cells [24].
In this study, we assessed how time and adipogenic and osteogenic differentiation treatments affect intracellular Ca2+ dynamics in ASCs. We measured the effects of time (7 days in vitro, DIV vs. 14 DIV vs. 21 DIV) and the differentiation protocol (adipogenic vs. osteogenic) on the fraction of differentiating ASCs exhibiting at least one spontaneous intracellular Ca2+ oscillation and on the interpeak interval (IPI) between oscillations.
This study represents a further step in characterising the association between intracellular Ca2+ oscillations and differentiation status of ASCs.

2. Materials and Methods

2.1. Cultivation of Human ASCs

Human ASCs from three non-diabetic adult donor lipoaspirates characterised at passage 1 were obtained from Lonza (Slough, UK). All ASCs have been characterised immunocytochemically and by tri-lineage differentiation assay as detailed by the manufacturer and as recommended by The International Society for Cellular Therapy [25]. All cells were used between passages 7 and 11. For biological replicates, ASCs within a range of 3 passages were used. ASCs have been characterised immunocytochemically and by tri-lineage differentiation assay as detailed by the manufacturer and as recommended by The International Society for Cellular Therapy [25]. All cells were used on or before passage 10. ASCs were cultivated in a standard medium composed of DMEM high glucose, 100U penicillin with 100 μg/mL streptomycin, 2 mM l-glutamine (all from Sigma-Aldrich, Gillingham, UK), 20% v/v heat-inactivated fetal bovine serum (FBS) (Sigma-Aldrich, lot: 8204188981) and 5 ng/mL fibroblast growth factor (FGF2) (Promega, Southampton, UK) at 37 °C and 10% CO2. Medium was changed every 2–3 days.

2.2. Osteogenic Differentiation

ASCs were seeded at a density of 6 × 105 mL on 13 mm glass cover slips (Agar Scientific, Stanstead, UK) pre-treated with nitric acid. After 72 h, standard medium was replaced by StemPro® Osteocyte basal medium supplemented with StemPro® osteogenesis supplement according to manufacturer’s instructions (Life Technologies, Thermo Fisher Scientific, Loughborough, UK). Cells were cultivated for up to 21 days in a humidified incubator (Binder APT.lineTM C150, Binder, Tuttlingen, Germany) at 37 °C and 5% CO2. Media were changed every three days. Osteogenic differentiation was assessed by Alizarin Red S staining at day 21 as described [26]. Briefly, ASCs differentiated for 21 days were fixed for 15 min using 4% PFA followed by three wash steps using PBS with 5 min per wash step. Calcium deposition was visualised by staining the cells with 1% Alizarin Red S in double-deionised water (ddH2O, Sigma-Aldrich) at pH 4.3 for 5 min at room temperature followed by imaging using a Nikon A1R inverted confocal microscope (Nikon, Kingston upon Thames, UK).

2.3. Adipogenic Differentiation

ASCs were seeded at a density of 6 × 105 mL on 13 mm glass cover slips (Agar Scientific) pre-treated with nitric acid. After 72 h, standard medium was replaced by StemPro® adipocyte differentiation basal medium supplemented with StemPro® adipogenesis supplement (Life Technologies, Thermo Fisher Scientific). After 21 days, differentiation was assessed by Oil RedO staining as described earlier [27].

2.4. Calcium Imaging

Calcium imaging experiments were carried out at 7, 14, and 21 DIV since the application of the differentiation protocol. For each timepoint we have measured the effect of three separate differentiation treatments: adipogenic, osteogenic, and control. To perform calcium imaging experiments, the cells were loaded with Fluo-4, a non-ratiometric calcium sensitive fluorescent probe. Cells were washed with PBS (Sigma-Aldrich) and treated with a loading solution containing Hanks’ Balanced Salt Solution (1×), 0.5 mM MgCl2, 1.3 mM CaCl2, 25 mM HEPES pH 7.4, 2.5 mM Probenecid (Sigma-Aldrich), and 2.5 µM Fluo-4 AM cell permeant (Invitrogen). Following a 45 min incubation at 37 °C, each sample was washed with PBS (2 × 1 min). Subsequently, the samples were stored in an incubator (37 °C, 5% CO2) in the loading solution described above (without Fluo-4 AM) until the experiment was carried out (between 15 min and 2 h).
Individual samples were placed into a submerged style recording chamber and continuously perfused (1–3 mL/min) with loading solution (without Fluo-4 AM) and kept at 32 ± 1 °C with a continuous flow temperature controller (Scientifica LTD, Uckfield, UK). Cells were visualised with a 40× water dipping, long-working distance objective, using infrared, differential interference contrast microscopy. A field of view containing at least 10 cells was chosen. The scope was subsequently switched to 2-photon mode. Excitation of the fluorophore was elicited by a Titanium-Sapphire (Ti-Sa), pulsating IR laser (MaiTai, Spectra-Physics, Didcot, UK) with an 810 nm wavelength. The intensity of the laser beam was modulated with a motorised beam attenuator (average laser power 4–5 mW). Emitted fluorescence was detected with two fast oscillating mirrors connected to a Galvo-Galvo system (Scientifica Ltd., Uckfield, UK). The signal to noise ratio increased using photomultiplier tubes (average of 800 arbitrary units) detecting red and green photons. Regions of interest (ROI, 412 µm × 412 µm; 3 for each coverslip) were scanned for 20 min resulting in 912 frames (0.76 frame/s).

2.5. Image Processing and Analysis

Analysis of the 2-photon microscopy images was performed using the open source image processor Fiji ImageJ [28]. Over 3750 cells were counted, and over 1440 cells were singularly analysed for measuring the IPI.

2.6. Cell Activity

Cells showing at least one oscillation were selected and categorised as “active”. Figure S1 shows representative traces of the oscillations observed in each condition. Cells without peaks were classified as “non active” The activity in percentage was calculated as:
A c t i v i t y ( % ) = A c t i v e   c e l l s   i n   R O I × 100   T o t a l   c e l l   n u m b e r   i n   R O I
The ROIs were considered the source of variability as no significant discrepancy between ROI and single coverslips as sources of variability was observed (data not shown). Data are presented as Mean ± SEM (standard error of the mean).

2.7. Interpeak Interval

Cells showing at least two fluorescence peaks were selected and their boundaries were drawn with Fiji’s plug-in “freehand selection”. The peak was the local maximum point of the oscillation, detected with the peak detection tool from Origin 2018 (OriginLab, Stoke Mandeville Bucks, UK). The arbitrary fluorescence data obtained were exported to Origin 2018 (OriginLab, Stoke Mandeville Bucks, UK) for further analysis. Each peak’s timepoint and height was measured with the software Originlab 2018 (Originlab, Stoke Mandeville Bucks, UK). The IPI was measured as the difference between the 2nd and the 1st peak by arithmetic subtraction of the respective time of the peak.

2.8. Statistical Analysis

Statistics were performed using Excel and SPSS, as required. We tested the effect of time in vitro (7 DIV, 14 DIV, 21 DIV) and the respective treatment (adipogenic, osteogenic, control) on two separate dependent variables: (1) fraction of active cells, and (2) IPI. A 2-way Analysis of Variance (ANOVA) followed by pairwise comparisons (timepoints within treatment and treatment within timepoint) consisting of post-hoc t-tests with Bonferroni correction (confidence interval 95%) was used. p < 0.05 was the threshold adopted to reject the null hypothesis.

3. Results

The aim of this study was to measure changes of intracellular Ca2+ dynamics in ASCs undergoing osteogenic and adipogenic differentiation, respectively, at 7, 14 and 21 DIV.
First, we confirmed that ASCs treated with osteogenic differentiation medium showed extracellular, insoluble deposits of CaPO4 as shown by Alizarin RedS staining at 21 DIV (Figure 1A). Using 2-photon microscopy, we have also identified fluorescent deposits, which likely correspond to deposits of CaPO4, early as 7 DIV (Figure 1C, bottom panels: note the extracellular, fluorescent deposits). This observation confirmed that ASCs differentiated into osteocytes as early as 7 DIV. In addition, ASCs differentiated into adipocytes after 14 DIV. ASCs treated with adipogenic differentiation medium showed intracellular lipid droplets, positive for Oil Red O (Figure 1B) at 21 DIV. However, 2-photon microscopy revealed the presence of vacuoles already at 14 DIV but not at 7 DIV (Figure 1C, middle panels: note the large vacuoles). Finally, ASCs cultivated in standard medium did not show positive stain to neither Alizarin RedS nor Oil Red O staining (Figure 1A,B) and 2-photon microscopy did not reveal any deposit nor vacuole at any of the timepoints investigated (Figure 1C, top panels).
Subsequently, we assessed the effect of time and differentiation treatment on the Ca2+ dynamics. These were measured as (1) the fraction of cells showing at least one oscillation among the cells counted in each ROI (Figure 2) and (2) the IPI between two subsequent oscillations within those cells showing oscillations (Figure 3).

3.1. Effect of Time on Ca2+ Aynamics in ASCs Undergoing Separate Differentiation Aaths

Time in vitro had a significant effect on the fraction of cells showing Ca2+ oscillations (Figure 2A, Two-way ANOVA, F = 27.99, p < 0.001, Source of variability: DIV) and on the length of the IPI in active cells (i.e., those cells showing Ca2+ oscillations. Figure 3A, Two-way ANOVA, F = 23.02, p < 0.001, Source of variability: DIV). Over 90% of all untreated ASCs showed Ca2+ oscillations at both 7 (n = 9) and 14 DIV (n = 4; p > 0.05), with a drop to 40% at 21 DIV (n = 4; Figure 2A, left panel, p < 0.001). This observation was paralleled by the increase of the IPI at 21 days (n = 36; Figure 3A, left panel) compared to both 14 DIV (n = 36, p = 0.016) and 7 DIV (n = 79; p = 0.001). However, there was no difference in the IPI between 14 DIV and 7 DIV within control cells (p = 1). Less than 20% of cells undergoing adipogenic differentiation showed Ca2+ oscillations and time had no effect on the percentage of cells exhibiting activity at 7 DIV (n = 8), 14 DIV (n = 7) and 21 DIV (n = 6; Figure 2A, middle panel, Non-significant—NS). This observation was not paralleled by the IPI (Figure 3A, middle panel): in fact, cells undergoing adipogenic treatment showed an increase of the IPI from 7 DIV (n = 10) to 14 DIV (n = 4; p < 0.0001), followed by a subsequent decrease of the IPI at 21 DIV (n = 5; p = 0.03) in comparison to the 14 DIV timepoint. In addition, the IPI at 21 DIV was significantly longer than the one at 7 DIV (0.017). Finally, circa 60% of cells undergoing osteogenic differentiation showed Ca2+ oscillations at 7 DIV (n = 9). This value fell to around 40% at 14 DIV (n = 6; p < 0.001) to then return to the levels observed at 7 DIV, at 21 DIV (n = 4; Figure 2A, right panel). In addition, the IPI within the cells undergoing osteogenic differentiation followed a trend in time similar to the one observed in cells undergoing adipogenic treatment (Figure 3A, right panel). In fact, in these cells the IPI increased between 7 DIV and 14 DIV (p = 0.005) and 21 DIV (p = 0.011), with no difference between 14 and 21 DIV (p = 1).
For a detailed list of the pairwise comparisons between timepoints within each treatment, see Table 1.

3.2. Effect of Osteogenic and Adipogenic Aifferentiation on Ca2+ Aynamics in ASCs at Aifferent Timepoints

The type of differentiation treatment had a significant effect on the fraction of cells showing Ca2+ oscillations (Figure 2B, Two-way ANOVA, F = 369.61, p < 0.001, Source of variability: differentiation treatment) and on the IPI between Ca2+ oscillations in active cells (Figure 3B, Two-way ANOVA, F = 21.75, p < 0.001, Source of variability: differentiation treatment). Post-hoc t-tests with Bonferroni correction allowed us to conclude that adipogenic differentiation resulted in a reduced portion of active cells, compared to both controls (p < 0.001) and cells undergoing osteogenic differentiation (p < 0.001) at all the considered timepoints (Figure 2B). Cells undergoing osteogenic differentiation exhibited reduced activity compared with controls, both at 7 DIV and 14 DIV (Figure 2B, left and middle panel, p < 0.001 at both timepoints), but higher activity at 21 DIV (Figure 2B, right panel, p < 0.001). These observations were partially paralleled by differentiation-dependent changes of the IPI at each timepoint. First, the treatment did not affect the IPI at 7 DIV. Secondly, cells undergoing adipogenic differentiation exhibited longer IPIs compared with controls and osteogenic cells at 14 DIV (p < 0.001). However, at 21 DIV, cells undergoing adipogenic treatment showed longer IPIs compared to those undergoing osteogenic treatment (p = 0.006) but not against controls (p = 0.4).
For a detailed list of the pairwise comparisons between timepoints within each treatment, see Table 2.
Finally, we observed that time and differentiation treatments interact to affect the fraction of cells showing Ca2+ oscillations (Two-way ANOVA, F = 46.62, p < 0.001, Source of variability: Time × Differentiation treatment). Finally, time and differentiation treatment interact in affecting the length of the IPI of Ca2+ oscillations (Two-way ANOVA, F = 7.28, p < 0.001, Source of variability: Time × Differentiation treatment).

4. Discussion

We investigated the effect of adipogenic and osteogenic differentiation treatments on the intracellular Ca2+ dynamics of ASCs at three different timepoints in vitro.
We noted that the different differentiation protocols led to the development of structural markers of differentiation. For example, we observed extracellular Ca2+ deposits positive to Alizarin Red S for the osteogenic treatment. 2-photon imaging revealed, in a nonspecific manner, the presence of Ca2+ deposits at 7 DIV in ASCs treated with the osteogenic medium. This increase in Ca2+ deposition was paralleled by an increased expression of mRNA for osteocalcin and osteopontin, molecular markers for osteogenic differentiation [26]. However, this observation was in contrast with a previous research work, which showed no increase in mRNA for osteocalcin or osteopontin in ASCs treated with osteogenic medium (21 DIV) [29]. Such discrepancy may be due methodological differences between the experimental conditions, such as the composition of the differentiation media. This, in turn, may underlie the presence of reservoirs of bone marker mRNAs in the cytoplasm of ASCs, which are translated in the presence of specific chemical and/or physical cues. Therefore, further investigation is needed to clarify the effect of osteogenic differentiation on molecular markers and its causal relationship with calcium deposition and oscillation. We have observed intracellular vacuoles positive to OilRedO, indicating adipogenic differentiation, for the sample treated with adipogenic differentiation medium, at 21DIVs. Once again, 2-photon imaging revealed presence of vacuoles already at 14 DIV in the sample treated with adipogenic medium.
Almost all the undifferentiated ASCs exhibited spontaneous Ca2+ oscillations (Figure 2A, left panel) with relatively short IPIs (Figure 3A, left panel), at 7 and 14 DIV. However, at 21 DIV less than 50% of ASCs exhibited oscillations (Figure 2A, left panel) and the length of the IPI increased by almost 100% compared to the 7 DIV timepoint (Figure 3A, left panel). This suggests that time has a significant effect in reducing the spontaneous Ca2+ dynamics in untreated ASCs. While it has already been shown that ASCs possess spontaneous Ca2+ oscillations (19-22), a time-dependent reduction in Ca2+ dynamics has not been previously shown. Therefore, future work aimed at establishing a correlation (and possibly a causal relation) between the properties of Ca2+ oscillations and cell differentiation, will be important to account for a possible biasing action of time on spontaneously occurring Ca2+ oscillations.
We observed that the adipogenic differentiation treatment generally reduced the Ca2+ dynamics, as less than 20% of cells exhibited Ca2+ oscillations at any measured timepoint (Figure 2A, middle panel) and those with a Ca2+ oscillations had IPIs exceeding 200 s (Figure 3A, middle panel). This observation is novel, as previous studies on the role of intracellular Ca2+ oscillations in differentiating adipocytes, mostly focused on evoked rather than spontaneous Ca2+ transients [30]. While multiple studies have shown the pivotal role of Ca2+ signalling in adipogenesis [30,31,32], our data show a markedly significant decrease in the fraction of oscillating cells as early as 7 DIV from the initiation of the differentiation protocol (Figure 2B). A possible explanation of this discrepancy is that while the increase in intracellular Ca2+ might be the trigger to adipogenic differentiation, we measured a decrease in Ca2+ dynamics following the incubation of cells with an adipogenic differentiation medium. Although ASCs (at 7 DIV) undergoing adipogenic differentiation lacked vacuoles, indicating an undifferentiated state (Figure 1C, middle panels), there was a decreased fraction of cells with Ca2+ activity (Figure 2B). In addition, IPIs increased at 14 DIV only (Figure 3B), in comparison to time-matched controls and ASCs undergoing osteogenic differentiation. This observation is interesting because it suggests that the differentiation-dependent reduction in Ca2+ activity may be an early, functional marker of adipogenesis, preceding other structural and molecular changes typical of adipocytes, such as lipid-filled vacuoles. Analogously, the fraction of active ASCs undergoing adipogenic differentiation was significantly reduced at 14 and 21 DIV, in comparison to untreated ASCs and those undergoing osteogenic differentiation. However, the ASCs undergoing adipogenic differentiation had longer IPIs, in comparison to the other treatments only at 14 DIV and 21 DIV. We postulate that this is likely due to the effect of time in vitro reducing spontaneous Ca2+ dynamics in untreated ASCs.
We also examined the effect of osteogenic differentiation on Ca2+ dynamics. Overall, osteogenic differentiation is associated with a decrease of the fraction of active cells, (Figure 2B) and an increase of the length of the IPI (Figure 3B) compared to untreated ASCs. The reduction in Ca2+ dynamics associated with osteogenic differentiation over time that we observed is consistent with a previous study [33]. Interestingly, in our experimental set up we observed a reduction in the fraction of active cells at 14 DIV, followed by a recovery at 21 DIV (Figure 2A). This biphasic change deserves further investigation. The fraction of active cells undergoing osteogenic differentiation was consistently higher than that of ASCs undergoing adipogenic differentiation (Figure 2B) but lower than controls at 7 and 14 DIV. However, at 21 DIV, cells undergoing osteogenic differentiation show less activity in comparison to controls. The IPIs, while being consistently shorter than the ones of adipogenic cells (Figure 3B), were not significantly different to control values, except at 21 days, where the osteogenic values were slightly but significantly lower than the controls (Figure 3B). This latter observation may be due to the effect of time reducing Ca2+ dynamics in untreated ASCs, but not in ASCs undergoing osteogenic differentiation. This is interesting because the manipulation of Ca2+ signalling has been proposed as a pivotal mechanism for the induction of osteogenic differentiation [20,34,35], leading to the development of electrical stimulation-based systems to promote osteogenic differentiation, as a possible tool for bone regeneration [26,27]. As we have shown that spontaneous Ca2+ oscillations in untreated ASCs are reduced over time, it is plausible to speculate that external stimuli promoting sustained Ca2+ oscillations may be responsible for osteogenic differentiation. However, it cannot be excluded that the maintenance of Ca2+ oscillations over time may be an epiphenomenon following and not causing osteogenic differentiation.
Changes in Ca2+ oscillation properties have been previously associated with separate differentiation fates [35,36]. In addition, it has been shown by Sun et al. that human MSCs derived from bone marrow can undergo osteogenic differentiation following the application of both electrical and chemical differentiation-inducing stimuli. Their study illustrated that bone marrow-derived MSCs undergoing osteogenic differentiation showed a progressive reduction in the number of intracellular [Ca2+] spikes as differentiation progressed [35]. While our study partially confirms a time-dependent reduction of Ca2+ dynamics over time, this occurs in in adipose-derived, rather than bone marrow-derived MSCs undergoing osteogenic differentiation. In addition, we have also observed a similar reduction in active control cells. Furthermore, Sun et al. suggested that the changes in the intracellular Ca2+ dynamics of MSCs differentiating into osteocytes may be both a consequence and a cause of the differentiation [35]. More specifically, it has also been shown that Ca2+ oscillations in human MSCs are generated by a combination of extracellular and intracellularly stored Ca2+. Extracellular Ca2+ enters the cell via the activation of a plasma membrane voltage-gated Ca2+ channels, while intracellularly stored one can be released via the activation of IP3 sensitive Ca2+ channels on the endoplasmic reticulum, which can be activated as a downstream signalling event following the binding of a ligand to integrins and Gq-coupled receptors [35,37]. Therefore, it is possible to infer that specific pattern of electrical stimulation may lead to specific differentiation fates (such as adipogenic and osteogenic) by modulating the properties of the intracellular Ca2+ dynamics. It is still to be established; however, how and if the modulation of Ca2+ waves is causative of the differentiation process or an epiphenomenon. Future work aimed at establishing a correlation (and possibly a causal relation) between the properties of Ca2+ oscillations and cell differentiation, will be important to account for a possible biasing action of time on spontaneously occurring Ca2+ oscillations.

5. Conclusions

Our main observations are that spontaneously occurring Ca2+ oscillations in ASCs are reduced over time and by adipogenic differentiation, while they are maintained over time by osteogenic differentiation. This observation is important because some changes in Ca2+ dynamics occur in both the adipogenic and osteogenic treatments at 7 DIV, before the structural markers of adipocytes (lipid-filled vacuoles) appear. For this reason, Ca2+ dynamics should be further investigated as a potential early marker of differentiation. However, further research work is needed to assess the causal relationship between Ca2+ oscillation dynamics and cell fate.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/biom11101400/s1, Figure S1: Representative traces of Ca2+ oscillations in each investigated condition.

Author Contributions

F.T., D.W., G.S.C.: Project design. E.C.T.: Experiments and data analysis. M.B.: Experiments and image processing. F.T.: Primary manuscript preparation. F.T., D.W., G.S.C., E.C.T.: Manuscript revision. All authors have read and agreed to the published version of the manuscript.

Funding

E.C.T. has been supported by the Erasmus+ mobility programme of the European Union. MB was supported by a grant of the Ministry of National Education of the Republic of Turkey, grant number MEB1416.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data can be provided upon request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Andrzejewska, A.; Lukomska, B.; Janowski, M. Concise Review: Mesenchymal Stem Cells: From Roots to Boost. Stem Cells 2019, 37, 855–864. [Google Scholar] [CrossRef] [Green Version]
  2. Kharaziha, P.; Hellström, P.M.; Noorinayer, B.; Farzaneh, F.; Aghajani, K.; Jafari, F.; Telkabadi, M.; Atashi, A.; Honardoost, M.; Zali, M.R.; et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: A phase I–II clinical trial. Eur. J. Gastroenterol. Hepatol. 2009, 21, 1199–1205. [Google Scholar] [CrossRef] [PubMed]
  3. Mathiasen, A.B.; Qayyum, A.A.; Jorgensen, E.; Helqvist, S.; Fischer-Nielsen, A.; Kofoed, K.F.; Haack-Sørensen, M.; Ekblond, A.; Kastrup, J. Bone marrow-derived mesenchy-mal stromal cell treatment in patients with severe ischaemic heart failure: A randomized placebo-controlled trial (MSC-HF trial). Eur. Heart. J. 2015, 36, 1744–1753. [Google Scholar] [CrossRef] [Green Version]
  4. Connick, P.; Kolappan, M.; Patani, R.; Scott, M.A.; Crawley, C.; He, X.L.; Richardson, K.; Barber, K.; Webber, D.J.; Wheeler-Kingshott, C.A.M.; et al. The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: An open-label pre-test: Post-test study with blinded outcome as-sessments. Trials 2011, 12, 62. [Google Scholar] [CrossRef] [Green Version]
  5. Sharma, R.R.; Pollock, K.; Hubel, A.; McKenna, D. Mesenchymal stem or stromal cells: A review of clinical applications and man-ufacturing practices. Transfusion 2014, 54, 1418–1437. [Google Scholar] [CrossRef]
  6. Lee, R.H.; Pulin, A.; Seo, M.J.; Kota, D.J.; Ylostalo, J.; Larson, B.L.; Semprun-Prieto, L.; Delafontaine, P.; Prockop, D.J. Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6. Cell Stem Cell 2009, 5, 54–63. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Zanotti, L.; Sarukhan, A.; Dander, E.; Castor, M.; Cibella, J.; Soldani, C.; Trovato, A.E.; Ploia, C.; Luca, G.; Calvitti, M.; et al. Encapsulated mesenchymal stem cells for in vivo im-munomodulation. Leukemia 2013, 27, 500–503. [Google Scholar] [CrossRef] [PubMed]
  8. Timmers, L.; Lim, S.K.; Arslan, F.; Armstrong, J.S.; Hoefer, I.E.; Doevendans, P.A.; Piek, J.J.; El Oakley, R.M.; Choo, A.; Lee, C.N.; et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 2008, 1, 129–137. [Google Scholar] [CrossRef] [Green Version]
  9. Gnecchi, M.; He, H.; Liang, O.D.; Melo, L.G.; Morello, F.; Mu, H.; Noiseux, N.; Zhang, L.; Pratt, R.E.; Ingwall, J.S.; et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 2005, 11, 367–368. [Google Scholar] [CrossRef]
  10. Gnecchi, M.; He, H.; Noiseux, N.; Liang, O.D.; Zhang, L.; Morello, F.; Mu, H.; Melo, L.G.; Pratt, R.E.; Ingwall, J.S.; et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006, 20, 661–669. [Google Scholar] [CrossRef] [PubMed]
  11. Zuk, P.A.; Zhu, M.; Ashjian, P.; De Ugarte, D.A.; Huang, J.I.; Mizuno, H.; Alfonso, Z.C.; Fraser, J.K.; Benhaim, P.; Hedrick, M.H. Human Adipose Tissue Is a Source of Multipotent Stem Cells. Mol. Biol. Cell 2002, 13, 4279–4295. [Google Scholar] [CrossRef] [PubMed]
  12. Gimble, J.; Guilak, F. Adipose-derived adult stem cells: Isolation, characterization, and differentiation potential. Cytotherapy 2003, 5, 362–369. [Google Scholar] [CrossRef] [PubMed]
  13. Jervis, M.; Huaman, O.; Cahuascanco, B.; Bahamonde, J.; Cortez, J.; Arias, J.I.; Torres, C.G.; Peralta, O.A. Comparative analysis of in vitro proliferative, migratory and pro-angiogenic potentials of bovine fetal mesenchymal stem cells derived from bone marrow and adipose tissue. Vet. Res. Commun. 2019, 43, 165–178. [Google Scholar] [CrossRef] [PubMed]
  14. Mitchell, R.; Mellows, B.; Sheard, J.; Antonioli, M.; Kretz, O.; Chambers, D.; Zeuner, M.-T.; Tomkins, J.; Denecke, B.; Musante, L.; et al. Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration through synergistic action of extracellular vesicle cargo and soluble proteins. Stem Cell Res. Ther. 2019, 10, 116. [Google Scholar] [CrossRef] [PubMed]
  15. Liu, Y.; Holmes, C. Tissue Regeneration Capacity of Extracellular Vesicles Isolated From Bone Marrow-Derived and Adi-pose-Derived Mesenchymal Stromal/Stem Cells. Front. Cell Dev. Biol. 2021, 9, 308. [Google Scholar]
  16. Whitfield, J.F. Calcium Signals in Cell Proliferation, Differentiation, and Death. In Ion Channels and Ion Pumps: Metabolic and Endocrine Relationships in Biology and Clinical Medicine; Foà, P.P., Walsh, M.F., Eds.; Springer: New York, NY, USA, 1994; pp. 19–58. [Google Scholar]
  17. Berridge, M.J.; Bootman, M.; Lipp, P. Calcium—A life and death signal. Nature 1998, 395, 645–648. [Google Scholar] [CrossRef] [PubMed]
  18. De Pittà, M.; Volman, V.; Levine, H.; Pioggia, G.; De Rossi, D.; Ben-Jacob, E. Coexistence of amplitude and frequency modulations in intracellular calcium dynamics. Phys. Rev. E 2008, 77, 030903. [Google Scholar] [CrossRef] [Green Version]
  19. Kawano, S.; Shoji, S.; Ichinose, S.; Yamagata, K.; Tagami, M.; Hiraoka, M. Characterization of Ca2+ signaling pathways in human mesenchymal stem cells. Cell Calcium 2002, 32, 165–174. [Google Scholar] [CrossRef]
  20. Hanna, H.; Andre, F.M.; Mir, L.M. Electrical control of calcium oscillations in mesenchymal stem cells using microsecond pulsed electric fields. Stem Cell Res. Ther. 2017, 8, 91. [Google Scholar] [CrossRef] [Green Version]
  21. Kawano, S.; Otsu, K.; Kuruma, A.; Shoji, S.; Yanagida, E.; Muto, Y.; Yoshikawa, F.; Hirayama, Y.; Mikoshiba, K.; Furuichi, T. ATP autocrine/paracrine signaling induces calcium oscilla-tions and NFAT activation in human mesenchymal stem cells. Cell Calcium 2006, 39, 313–324. [Google Scholar] [CrossRef]
  22. Kawano, S.; Otsu, K.; Shoji, S.; Yamagata, K.; Hiraoka, M. Ca2+ oscillations regulated by Na+–Ca2+ exchanger and plasma mem-brane Ca2+ pump induce fluctuations of membrane currents and potentials in human mesenchymal stem cells. Cell Calcium 2003, 34, 145–156. [Google Scholar] [CrossRef]
  23. Gu, X.; Spitzer, N. Breaking the Code: Regulation of Neuronal Differentiation by Spontaneous Calcium Transients. Dev. Neurosci. 1997, 19, 33–41. [Google Scholar] [CrossRef]
  24. Resende, R.; Adhikari, A.; da Costa, J.; Lorençon, E.; Ladeira, M.; Guatimosim, S.; Kihara, A.; Ladeira, L. Influence of spontaneous calcium events on cell-cycle progression in embryonal carcinoma and adult stem cells. Biochim. Biophys. Acta (BBA)-Bioenerg. 2010, 1803, 246–260. [Google Scholar] [CrossRef] [Green Version]
  25. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8, 315–317. [Google Scholar] [CrossRef] [PubMed]
  26. Bicer, M.; Sheard, J.; Iandolo, D.; Boateng, S.Y.; Cottrell, G.S.; Widera, D. Electrical Stimulation of Adipose-Derived Stem Cells in 3D Nanofibrillar Cellulose Increases Their Osteogenic Potential. Biomolecules 2020, 10, 1696. [Google Scholar] [CrossRef] [PubMed]
  27. Bicer, M.; Cottrell, G.S.; Widera, D. Impact of 3D cell culture on bone regeneration potential of mesenchymal stromal cells. Stem Cell Res. Ther. 2021, 12, 31. [Google Scholar] [CrossRef] [PubMed]
  28. Schindelin, J.; Arganda-Carreras, I.; Frise, E.; Kaynig, V.; Longair, M.; Pietzsch, T.; Preibisch, S.; Rueden, C.; Saalfeld, S.; Schmid, B.; et al. Fiji: An open-source platform for biologi-cal-image analysis. Nat. Methods 2012, 9, 676–682. [Google Scholar] [CrossRef] [Green Version]
  29. Winkel, A.; Jaimes, Y.; Melzer, C.; Dillschneider, P.; Hartwig, H.; Stiesch, M.; Von Der Ohe, J.; Strauss, S.; Vogt, P.M.; Hamm, A.; et al. Cell culture media notably influence properties of human mesenchymal stroma/stem-like cells from different tissues. Cytotherapy 2020, 22, 653–668. [Google Scholar] [CrossRef] [PubMed]
  30. Shi, H.; Halvorsen, Y.-D.; Ellis, P.N.; Wilkison, W.O.; Zemel, M. Role of intracellular calcium in human adipocyte differentiation. Physiol. Genom. 2000, 3, 75–82. [Google Scholar] [CrossRef]
  31. Zhai, M.; Yang, D.; Yi, W.; Sun, W. Involvement of calcium channels in the regulation of adipogenesis. Adipocyte 2020, 9, 132–141. [Google Scholar] [CrossRef] [Green Version]
  32. Berridge, M.J.; Bootman, M.; Roderick, H. Calcium signalling: Dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4, 517–529. [Google Scholar] [CrossRef] [Green Version]
  33. Hanna, H.; Mir, L.M.; Andre, F.M. In vitro osteoblastic differentiation of mesenchymal stem cells generates cell layers with dis-tinct properties. Stem Cell Res. Ther. 2018, 9, 203. [Google Scholar] [CrossRef] [PubMed]
  34. Viti, F.; Landini, M.; Mezzelani, A.; Petecchia, L.; Milanesi, L.; Scaglione, S. Osteogenic Differentiation of MSC through Calcium Signaling Activation: Transcriptomics and Functional Analysis. PLoS ONE 2016, 11, e0148173. [Google Scholar] [CrossRef] [Green Version]
  35. Sun, S.; Liu, Y.; Lipsky, S.; Cho, M. Physical manipulation of calcium oscillations facilitates osteo differentiation of human mesen-chymal stem cells. FASEB J. 2007, 21, 1472–1480. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Titushkin, I.; Sun, S.; Shin, J.; Cho, M. Physicochemical control of adult stem cell differentiation: Shedding light on potential mo-lecular mechanisms. J. Biomed. Biotechnol. 2010, 2010, 743476. [Google Scholar] [CrossRef] [PubMed]
  37. Khatib, L.; Golan, D.E.; Cho, M. Physiologic electrical stimulation provokes intracellular calcium increase mediated by phospho-lipase C activation in human osteoblasts. FASEB J. 2004, 18, 1903–1905. [Google Scholar] [CrossRef]
Figure 1. Osteogenic and adipogenic differentiation of ASCs. ASCs were cultivated in standard control medium, or the respective differentiation medium for 7–21 days, followed by staining with DAPI, Alizarin RedS or OilRedO. (A) Alizarin RedS staining (magenta) revealed CaPO4 deposition in cells exposed to the osteogenic differentiation medium, whereas no Alizarin RedS signal was detected in control cells, at 21 DIV. Scale bar: 200 µm. (B) ASCs were exposed to adipogenic differentiation medium or standard medium (control) for 21 days followed by staining of lipid droplets using Oil Red O. Note: Oil Red O-stained lipid droplets in the cells treated with adipogenic differentiation medium (arrows) which was absent under control conditions, at 21 DIV. Scale bar: 50 µm (C) Differentiated and undifferentiated ACSs were loaded with Fluo-4 AM followed by live cell imaging using a 2-photon microscope. Ca2+ imaging was carried out. The top row shows untreated ASCs. The middle row shows adipogenic differentiation medium-treated ASCs: note the large vacuoles at 14 DIV and 21 DIV. The bottom row shows osteogenic differentiation medium-treated ASCs: note the extracellular deposits at 7 DIV, 14 DIV and 21 DIV. Scale bar: 100 µm.
Figure 1. Osteogenic and adipogenic differentiation of ASCs. ASCs were cultivated in standard control medium, or the respective differentiation medium for 7–21 days, followed by staining with DAPI, Alizarin RedS or OilRedO. (A) Alizarin RedS staining (magenta) revealed CaPO4 deposition in cells exposed to the osteogenic differentiation medium, whereas no Alizarin RedS signal was detected in control cells, at 21 DIV. Scale bar: 200 µm. (B) ASCs were exposed to adipogenic differentiation medium or standard medium (control) for 21 days followed by staining of lipid droplets using Oil Red O. Note: Oil Red O-stained lipid droplets in the cells treated with adipogenic differentiation medium (arrows) which was absent under control conditions, at 21 DIV. Scale bar: 50 µm (C) Differentiated and undifferentiated ACSs were loaded with Fluo-4 AM followed by live cell imaging using a 2-photon microscope. Ca2+ imaging was carried out. The top row shows untreated ASCs. The middle row shows adipogenic differentiation medium-treated ASCs: note the large vacuoles at 14 DIV and 21 DIV. The bottom row shows osteogenic differentiation medium-treated ASCs: note the extracellular deposits at 7 DIV, 14 DIV and 21 DIV. Scale bar: 100 µm.
Biomolecules 11 01400 g001aBiomolecules 11 01400 g001b
Figure 2. Both time and differentiation treatment affect the fraction of cells with Ca2+ oscillations. Untreated ASCs exhibited a significantly lower activity at 21 DIV ((A), left). Adipogenic treatment is associated with a strong reduction of the activity for all the timepoints ((A), middle) while the osteogenic treatment shows a decrease at 14 DIV and a subsequent increase at 21 DIV ((A), right). Cells undergoing adipogenic and osteogenic differentiation showed decreased activity, in comparison to controls, at 7 DIV ((B), left) and 14 DIV ((B), middle). However, the ASCs treated with osteogenic differentiation medium showed increased activity at 21 DIV vs. both the cells treated with adipogenic differentiation medium and control ones, while the adipogenic one was still lower than controls ((B), right). Multiple pairwise comparisons were carried out with t-test with Bonferroni correction: *** = p ≤ 0.001.
Figure 2. Both time and differentiation treatment affect the fraction of cells with Ca2+ oscillations. Untreated ASCs exhibited a significantly lower activity at 21 DIV ((A), left). Adipogenic treatment is associated with a strong reduction of the activity for all the timepoints ((A), middle) while the osteogenic treatment shows a decrease at 14 DIV and a subsequent increase at 21 DIV ((A), right). Cells undergoing adipogenic and osteogenic differentiation showed decreased activity, in comparison to controls, at 7 DIV ((B), left) and 14 DIV ((B), middle). However, the ASCs treated with osteogenic differentiation medium showed increased activity at 21 DIV vs. both the cells treated with adipogenic differentiation medium and control ones, while the adipogenic one was still lower than controls ((B), right). Multiple pairwise comparisons were carried out with t-test with Bonferroni correction: *** = p ≤ 0.001.
Biomolecules 11 01400 g002
Figure 3. Both time and differentiation treatment affect the IPIs duration of spontaneous Ca2+ oscillations. Untreated ASCs show increased interpeak intervals (IPI) at 21 days ((A), left), whereas cells exposed to adipogenic differentiation medium show an increase at 14 DIV and 21 DIV in comparison to 7 DIV, with a reduction at 21 DIV in comparison to 14 DIV ((A), middle). The osteogenic samples show an increase in IPI at 14 DIV and 21 DIV in comparison to 7 DIV, but no difference was observed between 14 DIV and 21 DIV ((A), right). No difference in the IPI was observed across treatments at 7 DIV ((B), left). The adipogenic sample showed IPIs which were longer than those of controls and the osteogenic sample at 14 DIV ((B), centre). Finally, at 21 DIV the adipogenic sample showed longer IPIs in comparison to those observed in the osteogenic one, but no difference was observed between controls and either treatment ((B), right). Multiple pairwise comparisons were carried out with t-test with Bonferroni correction: *** = p ≤ 0.001, ** = p < 0.05.
Figure 3. Both time and differentiation treatment affect the IPIs duration of spontaneous Ca2+ oscillations. Untreated ASCs show increased interpeak intervals (IPI) at 21 days ((A), left), whereas cells exposed to adipogenic differentiation medium show an increase at 14 DIV and 21 DIV in comparison to 7 DIV, with a reduction at 21 DIV in comparison to 14 DIV ((A), middle). The osteogenic samples show an increase in IPI at 14 DIV and 21 DIV in comparison to 7 DIV, but no difference was observed between 14 DIV and 21 DIV ((A), right). No difference in the IPI was observed across treatments at 7 DIV ((B), left). The adipogenic sample showed IPIs which were longer than those of controls and the osteogenic sample at 14 DIV ((B), centre). Finally, at 21 DIV the adipogenic sample showed longer IPIs in comparison to those observed in the osteogenic one, but no difference was observed between controls and either treatment ((B), right). Multiple pairwise comparisons were carried out with t-test with Bonferroni correction: *** = p ≤ 0.001, ** = p < 0.05.
Biomolecules 11 01400 g003
Table 1. Pairwise comparisons between timepoints within each treatment. p values have been calculated using unpaired Student’s t-tests with Bonferroni correction.
Table 1. Pairwise comparisons between timepoints within each treatment. p values have been calculated using unpaired Student’s t-tests with Bonferroni correction.
TreatmentDIV (I)DIV (J)Fraction of Active CellsInterpeak Intervals
Effect Size (Mean Difference: I–J)p (Bonferroni Corrected)Effect Size (Mean Difference: I–J)p (Bonferroni Corrected)
control714−1.9851.000−9.0201.000
2153.274<0.001−91.3190.001
1471.9851.0009.0201.000
2155.258<0.001−82.2980.016
217−53.274<0.00191.3190.001
14−55.258<0.00182.2980.016
adipogenic7140.9321.000−407.0500.000
217.9440.130−190.2740.017
147−0.9321.000407.0500.000
217.0130.244216.7760.030
217−7.9440.130190.2740.017
14−7.0130.244−216.7760.030
osteogenic71423.905<0.001−96.8690.005
21−8.1240.187−77.9120.011
147−23.905<0.00196.8690.005
21−32.029<0.00118.9571.000
2178.1240.18777.9120.011
1432.029<0.001−18.9571.000
Table 2. Pairwise comparisons between treatments within each timepoint. p values have been calculated using unpaired Student’s t-tests with Bonferroni correction.
Table 2. Pairwise comparisons between treatments within each timepoint. p values have been calculated using unpaired Student’s t-tests with Bonferroni correction.
DIVTreatment (I)Treatment (J)Fraction of Active CellsInterpeak Intervals
Effect Size (Mean Difference: I–J)p (Bonferroni Corrected)Mean Difference (I–J)p (Bonferroni Corrected)
7controladipogenic75.226<0.001−41.4350.965
osteogenic26.774<0.00130.0310.510
adipogeniccontrol−75.226<0.00141.4350.965
osteogenic−48.451<0.00171.4660.287
osteocontrol−26.774<0.001−30.0310.510
adipogenic48.451<0.001−71.4660.287
14controladipogenic78.142<0.001−439.465<0.001
osteogenic52.664<0.001−57.8180.236
adipogeniccontrol−78.142<0.001439.465<0.001
osteogenic−25.478<0.001381.647<0.001
osteogeniccontrol−52.664<0.00157.8180.236
adipogenic25.478<0.001−381.647<0.001
21controladipogenic29.896<0.001−140.3900.056
osteogenic−34.623<0.00143.4370.418
adipogeniccontrol−29.896<0.001140.3900.056
osteogenic−64.520<0.001183.8270.006
osteogeniccontrol34.623<0.001−43.4370.418
adipogenic64.520<0.001−183.8270.006
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Torre, E.C.; Bicer, M.; Cottrell, G.S.; Widera, D.; Tamagnini, F. Time-Dependent Reduction of Calcium Oscillations in Adipose-Derived Stem Cells Differentiating towards Adipogenic and Osteogenic Lineage. Biomolecules 2021, 11, 1400. https://doi.org/10.3390/biom11101400

AMA Style

Torre EC, Bicer M, Cottrell GS, Widera D, Tamagnini F. Time-Dependent Reduction of Calcium Oscillations in Adipose-Derived Stem Cells Differentiating towards Adipogenic and Osteogenic Lineage. Biomolecules. 2021; 11(10):1400. https://doi.org/10.3390/biom11101400

Chicago/Turabian Style

Torre, Enrico C., Mesude Bicer, Graeme S. Cottrell, Darius Widera, and Francesco Tamagnini. 2021. "Time-Dependent Reduction of Calcium Oscillations in Adipose-Derived Stem Cells Differentiating towards Adipogenic and Osteogenic Lineage" Biomolecules 11, no. 10: 1400. https://doi.org/10.3390/biom11101400

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop